Released on: September 2, 2008, 11:28 am

Press Release Author: David Menzies for Drug Safety Alliance

Industry: Biotech

Press Release Summary: (Research Triangle Park, N.C.) Drug Safety Alliance (DSA), a
global leader in pharmaceutical safety and pharmacovigilance, has announced the
addition of industry veteran Deena B. Wegner as vice president, business development
and strategy.


Press Release Body: Wegner brings over 25 years of pharmaceutical and contact
research organization experience to Drug Safety Alliance, having held senior
leadership roles at Research Triangle Institute-Health Solutions, Integrated Safety
Systems, Inc., and Berlex Laboratories. She is an active member of the Drug
Information Association, Council for Entrepreneurial Development, and is Past
President of the Healthcare Business Women’s Association RTP Chapter.

“Deena’s experience and passion for patient safety is a solid fit with our staff of
healthcare professionals and experienced pharmacovigilance professionals,” Cathy
Stokes, DSA president and CEO said. “Our vast experience in drug safety across the
DSA team makes us unique in the industry and Deena will help us reach companies in
need of global safety support, better IT options, and good risk mitigation and
management strategies.”

Drug Safety Alliance assists in the development of drug safety plans that help
pharmaceutical companies identify who should and should not use certain medications.
In her new executive position, Wegner is responsible for DSA’s strategic planning
and global partnerships and alliances, in addition to sales and marketing execution
and new services positioning.

“Drug companies are taxed with the very complex and expensive process of maintaining
information, reporting results, and conducting risk assessments for FDA and other
agencies around the world. Most companies do not have internal expertise or the
workforce to do this; that’s where DSA can help,” Wegner said. “All drugs carry
risks, but by monitoring the adverse events , companies can identify trends and risk
factors to ensure the drugs are used properly and in the right patients – that’s why
it is so important to keep on top of the information.”

Wegner graduated from Tulane University with a B.S. in Biology.

About Drug Safety Alliance
Founded in 2000, Drug Safety Alliance (DSA) provides pharmacovigilance expertise to
large and small pharmaceutical and biotechnology companies to help them develop safe
drugs and improve patient safety. DSA\'s mission is to partner with clients to
mitigate their drug safety risks and to maximize product longevity and value. Driven
by the highest ethical standards, DSA is uniquely focused to provide high-quality
pre- and post-market drug safety services including domestic and international
regulatory compliance, safety database support and hosting options, risk management
and adverse event case management. DSA is headquartered in the Research Triangle
Park region of North Carolina with strategic partnerships worldwide. For more
information please visit www.DrugSafetyAlliance.com.


Web Site: http://www.drugsafetyalliance.com

Contact Details: David Menzies
105 Pinewood Dr.
Apex, NC 27502
919-373-4274
dmenzies@menziesconsulting.com